H1 FY26 Results
| Stock | Cleanspace Holdings Ltd (CSX.ASX) |
|---|---|
| Release Time | 26 Feb 2026, 8:51 a.m. |
| Price Sensitive | Yes |
CleanSpace Reports H1 FY26 Results
- Sustained revenue growth with strong margins
- Improved cash balance and operating EBITDA
- Revised FY26 revenue growth of ~15% and positive operating EBITDA for H2FY26
CleanSpace Holdings Limited, an Australian company that designs, manufactures, and sells premium respiratory protection solutions, has reported its H1 FY26 results. The company achieved sustained revenue growth with strong margins, reporting revenue of $10.1M, a 10% increase over the prior corresponding period (pcp). Gross margin strengthened to 75%, up from 74% in the pcp, due to continuous improvement initiatives. The company's cash balance improved to $9.8M, an 18% increase compared to the pcp. Operating EBITDA improved by 25% to -$0.3M, driven by disciplined cost management while investing in future growth. The company received an R&D tax refund of ~$0.9M in February 2026. Regionally, Europe delivered another strong result, with growth led by West Europe and the Nordic region, reflecting continued market penetration and distributor execution. Asia Pacific and Rest of World declined by 22%, partly reflecting the timing of one-off business wins in the prior year, but the company expects sales momentum to improve as product certifications are secured and the regional distribution network further matures. North America delivered 8% growth, driven by the team established in 2025 and increasing direct engagement with end-users. The company's operating expenses increased by 8%, primarily due to higher sales and marketing investments and R&D, consistent with the company's strategy to invest in growth. The board remains confident in the company's strategy and expects revenue growth of approximately 15% for FY26, maintaining strong gross margins in the mid-70% range, achieving positive operating EBITDA in H2, and positive cash flow for the full year.
Revenue growth of ~15% for FY26, gross margin in the mid-70% range, positive operating EBITDA for H2FY26, and positive cash flow for the full year.
The board remains confident that the company's strategy will support profitable growth in the near-term, with a focus on disciplined execution, strengthening commercial capability, and accelerating innovation.